News and Updates

Arletta Pharma hits a key milestone for Lybrido, a novel treatment for HSDD. Discover how this FDA-backed therapy aims to transform female sexual health.

Ambient AI is evolving from passive recording to active data curation in clinical trials. Explore how these systems filter data and impact trial integrity.

New real-world data confirms Leqembi effectively slows early-stage Alzheimer’s progression. Learn about the latest clinical insights and patient outcomes.

Sellas Life Sciences shares rise 12% as investors await pivotal clinical trial results that could define the company’s future in oncology treatment.

New research shows Proton FLASH radiotherapy provides rapid, effective pain relief for thoracic bone metastases, potentially transforming palliative care.

New ASRS 2026 data shows that an AI screening platform significantly increases patient randomization, accelerating clinical trials for retinal diseases.

Regeneron investors are bracing for the September 14, 2026, patent expiration. Learn how this shift impacts market strategy and future drug pipelines.

The FDA is intensifying scrutiny on Novo Nordisk and Alvotech manufacturing sites after recent project rejections. Learn how these firms are responding.

Ananda Pharma has dosed its first patient in an NIHR-backed trial targeting Chemotherapy-Induced Peripheral Neuropathy (CIPN). Learn more about the study.

A recent clinical trial shows that olanzapine may significantly reduce postoperative nausea. Learn how this drug could improve surgical recovery outcomes.